| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-11 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-09 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-07 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-07 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |